Received: 14 February 2020
Revised: 5 March 2020
Accepted: 11 March 2020
First Online: 20 March 2020
Compliance with ethical standards
: FAY reports associations with Endo Pharmaceuticals as consultant and speaker; Antares Pharma as consultant and speaker; Coloplast as speaker and advisory board; and Viome as clinical trial primary investigator. All other authors declare that they have no conflict of interest.